Abstract
Background
The proportion of patients with functional movement disorders (FMD) is particularly high in neurology clinics. Treatment options have not been consistently developed, not well evaluated and not validated. This article presents the preliminary data on the prevalence and treatment response of patients with FMD who were treated within the framework of an early rehabilitative geriatric complex treatment at a university hospital for neurology.
Methods
From July 2017 to November 2018 the prevalence, demographic and clinical parameters, and response to treatment of FMD patients were documented and compared to non-FMD patients treated at the neurogeriatric ward of the University Hospital Schleswig-Holstein, in Kiel. Clinical endpoints were the Short Physical Performance Battery (SPPB) for mobility and the Barthel index for instrumented activity of daily life (iADL).
Results
The prevalence of FMD was 11% (19/175) and predominantly observed in women (74%). Of the FMD patients nine also had a diagnosis of either idiopathic Parkinson’s disease (N = 7), dementia with Lewy bodies (N = 1) or progressive supranuclear palsy (N = 1). At admission, neither the SPPB nor the iADL differed significantly between FMD and non-FMD patients. The treatment response was comparable between the groups: SPPB change was +0.3±1.8 (mean, standard deviation) in FMD and +0.4±1.9 in non-FMD patients (p = 0.83). The iADL change was +19±15 in FMD and +18±17 in non-FMD (p = 0.83).
Conclusion
The prevalence of FMD was unexpectedly high in the neurogeriatric ward of a German university hospital. There were comparable impairments and responses to multidisciplinary treatment in mobility and iADL between FMD and non-FMD geriatric patients, suggesting that specific and informed treatment provided by a multidisciplinary geriatric team is effective in geriatric FMD patients. Further studies of this underdiagnosed disorder in older age are warranted.
Zusammenfassung
Hintergrund
Der Anteil von Patienten mit funktionellen Bewegungsstörungen (FBS) ist vor allem im neurologischen Fachgebiet relativ hoch. Therapeutische Optionen sind nicht konsequent entwickelt, nicht gut evaluiert und nicht validiert. Die hier vorgestellte Analyse präsentiert erste Daten zu Prävalenz und Therapieansprechen von Patienten mit FBS, die im Rahmen der frührehabilitativen geriatrischen Komplexbehandlung an einer neurologischen Universitätsklinik behandelt wurden.
Methoden
Auf der neurogeriatrischen Station des Universitätsklinikums Schleswig-Holstein Campus Kiel wurde über den Zeitraum von Juli 2017 bis November 2018 der prozentuale Anteil von Patienten mit FBS bestimmt. Danach wurde in diesen FBS-Patienten die Mobilität („short physical performance battery“, SPPB) sowie die Schwere der Beeinträchtigung der instrumentellen Aktivität des täglichen Lebens (Barthel-Index) bestimmt und mit den Daten der Nicht-FBS-Patienten verglichen.
Ergebnisse
Der Anteil von Patienten mit FBS (N = 19) am Gesamtkollektiv (N = 175) lag bei 11 %. Der Anteil von Frauen lag bei 74 %. Neun der FBS-Patienten hatten zusätzlich die Diagnose einer neurodegenerativen Bewegungsstörung (7 idiopathisches Parkinson-Syndrom, 1 Demenz mit Lewy-Körpern, 1 progressive supranukleäre Blickparese). Bei Aufnahme zeigten sich keine signifikanten Unterschiede in der SPPB oder im Barthel-Index zwischen FBS- und Nicht-FBS-Patienten. Mit Delta SPPB von +0,3 (1,8) versus +0,4 (1,9; M [SD]; p = 0,83) und Delta Barthel-Index von +19 (15) vs. +18 (17) Punkten (p = 0,83) zeigten sich keine relevanten Unterschiede hinsichtlich Therapieerfolg zwischen FBS und Nicht-FBS.
Schlussfolgerung
Der Anteil von Patienten mit FBS auf einer neurogeriatrischen Station an einer deutschen Universitätsklinik zeigt sich überraschend hoch. Erste Analysen deuten darauf hin, dass FBS-Patienten bei Zuweisung ähnlich schwer betroffen sind wie Nicht-FBS-Patienten und sie von der angebotenen Struktur und Behandlung durch das multidisziplinäre geriatrische Team auch ähnlich effektiv profitieren. Dies ist aufgrund der bestehenden Literatur nicht selbsterklärend und bedarf weiterer wissenschaftlicher Aufarbeitung.
Similar content being viewed by others
References
Morgante F, Edwards MJ, Espay AJ (2013) Psychogenic movement disorders. Continuum (N Y) 19(5):1383–1396
Edwards MJ, Stone J, Lang AE (2014) From psychogenic movement disorder to functional movement disorder: It’s time to change the name. Mov Disord 29(7):849–852
Thenganatt MA (2015) Psychogenic movement disorders. Neurol Clin 33(1):205–224
Edwards MJ, Bhatia KP (2012) Functional (psychogenic) movement disorders: merging mind and brain. Lancet Neurol 11(3):250–260
Batla A, Stamelou M, Edwards MJ, Pareés I, Saifee TA, Fox Z et al (2013) Functional movement disorders are not uncommon in the elderly. Mov Disord 28(4):540–543
Espay AJ, Lang AE (2015) Phenotype-specific diagnosis of functional (psychogenic) movement disorders. Curr Neurol Neurosci Rep 15(6):32. https://doi.org/10.1007/s11910-015-0556-y
Hallett M (2016) Functional (psychogenic) movement disorders—clinical presentations. Parkinsonism Relat Disord 22(Suppl 1):149–152
Pareés I, Saifee TA, Kojovic M, Kassavetis P, Rubio-Agusti I, Sadnicka A et al (2013) Functional (psychogenic) symptoms in Parkinson’s disease. Mov Disord 28(12):1622–1627
Wissel BD, Dwivedi AK, Merola A, Chin D, Jacob C, Duker AP et al (2018) Functional neurological disorders in Parkinson disease. J Neurol Neurosurg Psychiatry 89(6):566–571
Jordbru AA, Smedstad LM, Klungsøyr O, Martinsen EW (2014) Psychogenic gait disorder: a randomized controlled trial of physical rehabilitation with one-year follow-up. J Rehabil Med 13:181–187
Sharma VD, Jones R, Factor SA (2017) Psychodynamic psychotherapy for functional (psychogenic) movement disorders. J Mov Disord 10(1):40–44
Nielsen G, Stone J, Matthews A, Brown M, Sparkes C, Farmer R et al (2015) Physiotherapy for functional motor disorders : a consensus recommendation. J Neurol Neurosurg Psychiatry 86(10):1113–1119
Czarnecki K, Thompson JM, Seime R, Geda YE, Duffy JR, Ahlskog JE (2012) Functional movement disorders: successful treatment with a physical therapy rehabilitation protocol. Parkinsonism Relat Disord 18(3):247–251
Schwarz J, Maetzler W (2019) Funktionelle Störungen. Neurogeriatrie. Springer, Berlin Heidelberg, pp 293–301
Ricciardi L, Edwards MJ (2014) Treatment of functional (psychogenic) movement disorders. Neurotherapeutics 11(1):201–207
Maetzler W, Grond M, Jacobs AH (2016) Neurogeriatrie. Neurologie. Springer, Berlin Heidelberg, pp 959–970
Sieber CC (2007) The elderly patient—who is that? Internist (Berl) 48(1190):1192–1194
Johnston MC, Crilly M, Black C, Prescott GJ, Mercer SW (2019) Defining and measuring multimorbidity: a systematic review of systematic reviews. Eur J Public Health. https://doi.org/10.1093/eurpub/cky098
Stone J, Edwards M (2012) Trick or treat?: showing patients with functional (psychogenic) motor symptoms their physical signs. Baillieres Clin Neurol 79(3):282–284
Heidenblut S, Zank S (2010) Development of a new screening instrument for geriatric depression. The depression in old age scale (DIA-S). Z Gerontol Geriatr 43(3):170–176
Treacy D, Hassett L (2018) The short physical performance battery. J Physiother 64(1):61
Freire AN, Guerra RO, Alvarado B, Guralnik JM, Zunzunegui MV (2012) Validity and reliability of the short physical performance battery in two diverse older adult populations in Quebec and Brazil. J Aging Health 24(5):863–878
Heuschmann PU, Kolominsky-Rabas PL, Nolte CH, Hünermund G, Ruf HU, Laumeier I et al (2005) Untersuchung der Reliabilität der Deutschen Version des Barthel-Index sowie Entwicklung einer postalischen und telefonischen Fassung für den Einsatz bei Schlaganfall-Patienten. Fortschritte Neurol Psychiatr 73(2):74–82
Lübke N, Meinck M, Von Renteln-Kruse W (2004) Der Barthel-Index in der Geriatrie. Eine Kontextanalyse zum Hamburger Einstufungsmanual. Z Gerontol Geriatr 37(4):316–326
Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W et al (2015) MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord 30(12):1591–1601
McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor J‑P, Weintraub D et al (2017) Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB consortium. Neurology 89(1):88–100
Höglinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE et al (2017) Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov Disord 32(6):853–864
Carrozzino D, Bech P, Patierno C, Onofrj M, Morberg BM, Thomas A et al (2017) Somatization in parkinson’s disease: a systematic review. Prog Neuropsychopharmacol Biol Psychiatry 78:18–26
Gupta A, Lang AE (2009) Psychogenic movement disorders. Curr Opin Neurol 22(4):430–436
Espay AJ, Aybek S, Carson A, Edwards MJ, Goldstein LH, Hallett M et al (2018) Current concepts in diagnosis and treatment of functional neurological disorders. JAMA Neurol 75:1132–1141
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
S. Mätzold, J. Geritz, K.E. Zeuner, D. Berg, S. Paschen, J. Hieke, S. Sablowsky, C. Ortlieb, P. Bergmann, W. Hofmann, A.J. Espay and W. Maetzler declare that they have no competing interests.
All procedures performed in studies involving human participants or on human tissue were in accordance with the ethical standards of the institutional and/or national research committee (ethics committee of the Faculty of Medicine, Christian-Albrechts-Universität zu Kiel [No D427/17]) and with the 1975 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.
Additional information
S. Mätzold and J. Geritz contributed equally.
Rights and permissions
About this article
Cite this article
Mätzold, S., Geritz, J., Zeuner, K.E. et al. Functional movement disorders in neurogeriatric inpatients. Z Gerontol Geriat 52, 324–329 (2019). https://doi.org/10.1007/s00391-019-01562-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00391-019-01562-y